Diclofenac’s peripheral analgesic results are attributable to its action in lowering the availability of sensitized peripheral soreness receptors through down-regulation, which appears for being achieved by stimulating the L-arginine nitric oxide cGMP pathway through activation of ATP-sensitive potassium channels. Postmarketing surveillance has noted scenarios of intense hepatic react... https://haimw000sle2.wikigiogio.com/user